These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28923903)

  • 1. The Absence of an Ideal Observer: Why Some Clinical Trials May Not Be What We Think They Are.
    Packer M
    Circulation; 2017 Sep; 136(12):1085-1086. PubMed ID: 28923903
    [No Abstract]   [Full Text] [Related]  

  • 2. Learning from OCTET - exploring the acceptability of clinical trials management methods.
    Arundel C; Gellatly J
    Trials; 2018 Jul; 19(1):378. PubMed ID: 30005659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conflict of interest: will it ever end?
    Carney SL
    Intern Med J; 2012 Nov; 42(11):1255-6. PubMed ID: 23157520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trust in the medical literature--and Viewpoints in JAMA Internal Medicine.
    Steinbrook R; Redberg RF
    JAMA Intern Med; 2013 Jun; 173(12):1047-8. PubMed ID: 23609117
    [No Abstract]   [Full Text] [Related]  

  • 5. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative.
    Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ
    Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transparency codex of the VFA (Association of Research-Based Pharmaceutical Companies). Why cooperation should be visible].
    Laschet H
    MMW Fortschr Med; 2014 Jul; 156(13):20-1. PubMed ID: 25318209
    [No Abstract]   [Full Text] [Related]  

  • 7. Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases.
    Filippatos GS; de Graeff P; Bax JJ; Borg JJ; Cleland JG; Dargie HJ; Flather M; Ford I; Friede T; Greenberg B; Henon-Goburdhun C; Holcomb R; Horst B; Lekakis J; Mueller-Velten G; Papavassiliou AG; Prasad K; Rosano GM; Severin T; Sherman W; Stough WG; Swedberg K; Tavazzi L; Tousoulis D; Vardas P; Ruschitzka F; Anker SD
    Eur J Heart Fail; 2017 Apr; 19(4):449-456. PubMed ID: 28271595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Money and medical science.
    Fielder J
    IEEE Eng Med Biol Mag; 2001; 20(1):114-6. PubMed ID: 11211653
    [No Abstract]   [Full Text] [Related]  

  • 9. Ensuring trial conduct is consistent with trial design: assumption is the enemy of quality.
    Kelly J; Hounsome B; Lambert G; Murphy C
    Trials; 2019 Jul; 20(1):416. PubMed ID: 31291974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transparency in cooperation. Sensitivity has grown (interview by Helmut Laschet)].
    Fischer B; Jonitz G
    MMW Fortschr Med; 2014 Jul; 156(13):18-9. PubMed ID: 25318208
    [No Abstract]   [Full Text] [Related]  

  • 11. Falling out with pharma.
    Whitehead S
    Lancet; 2013 Mar; 381(9872):1096-7. PubMed ID: 23540851
    [No Abstract]   [Full Text] [Related]  

  • 12. [From the design of use study to the assessment of the benefit: with or without pharmaceutical industry?].
    Porzsolt F
    Med Klin (Munich); 2010 Dec; 105(12):930-5. PubMed ID: 21240593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data-Driven Collaboration: How physicians and administration can team up to improve outcomes.
    Briscoe MB; Carlisle B; Cerfolio RJ
    Healthc Financ Manage; 2016 Jul; 70(7):42-9. PubMed ID: 29893528
    [No Abstract]   [Full Text] [Related]  

  • 14. Industry and the academy: conflicts of interest in contemporary health research.
    Downie J; Baird P; Thompson J
    Health Law J; 2002; 10():103-22. PubMed ID: 14748274
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trials in India: balancing economic opportunity with the public health context.
    Dandona L
    Natl Med J India; 2006; 19(2):57-9. PubMed ID: 16756189
    [No Abstract]   [Full Text] [Related]  

  • 16. [The Coordinating Centres for Clinical Trials Network. Objectives and significance for research sites].
    Bruns I; Maier-Lenz H; Wolff S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):451-8. PubMed ID: 19277472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information.
    Puttagunta PS; Caulfield TA; Griener G
    Health Law Rev; 2002; 10(2):30-2. PubMed ID: 15739309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Constraints on publication rights in industry-initiated clinical trials--secondary publication].
    Gøtzsche PC; Hróbjartsson A; Johansen HK; Haahr MT; Altman DG; Chan AW
    Ugeskr Laeger; 2006 Jun; 168(25):2467-9. PubMed ID: 16824372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Less than the truth.
    Rowe T
    J Obstet Gynaecol Can; 2013 Nov; 35(11):971-972. PubMed ID: 24246393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.